Reverse flows within the pharmaceutical supply chain: A classificatory review from the perspective of end-of-use and end-of-life medicines

Viegas, Claudia Viviane, Bond, Alan ORCID: https://orcid.org/0000-0002-3809-5805, Rodrigues Vaz, Caroline and João Bertolo, Rubem (2019) Reverse flows within the pharmaceutical supply chain: A classificatory review from the perspective of end-of-use and end-of-life medicines. Journal of Cleaner Production, 238. ISSN 0959-6526

Preview

PDF (Accepted_Manuscript) - Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (3MB) | Preview

Abstract

The Pharmaceutical Supply Chain (PSC) is responsible for considerable environmental and product-value impacts. However, studies on the reverse flows of PSC do not capture the diverse routes of end-of-use and end-of-life medicines (EOU/EOL-M) and how the constraints in the forward supply chain processes and operations impact such reverse flows. This research proposes a classificatory review in which three categories of reverse flows are identified: donations, Reverse Logistics (RL) and Circular Economy (CE). Donations are characterized by explicit philanthropic acts involving corporate reputation or by emergency humanitarian action. RL is boosted by regulatory issues and restricted by business imperatives of the PSC. CE is characterized by informal loops of not expired medicines, mainly due to health professionals’ initiatives (although this may not be clear to participants). This classification emerged from content analysis of 2,622 references found in six databases, from which 127 were selected. Three questions guided the review in each category: (i) what are the elements of the forward PSC processes that impact PSC reverse flows?; (ii) in what stages of the PSC are the reverse flows identified?; (iii) what does the academic literature recommend for improving PSC reverse flows? The literature shows that excessive amounts and inappropriate types of medicines hinder donations. Inventory planning and quality control problems are the main difficulties for medicines RL. The circularity of EOU-M is affected significantly by frequent changes of patient therapies and health conditions, and by failures of healthcare agents in monitoring prescriptions. The proposed classification suggests that the circularity of not expired medicines is not yet researched in the field of logistics, supply chain and procurement, and it is scarcely considered in engineering, and business and management areas, which evokes a call for future research agenda.

Item Type:	Article
Uncontrolled Keywords:	pharmaceutical supply chain,medicines wastes,reverse flows,. reverse logistics (rl),circular economy (ce),environmental science(all),pharmacology, toxicology and pharmaceutics(all),sdg 8 - decent work and economic growth,sdg 12 - responsible consumption and production ,/dk/atira/pure/subjectarea/asjc/2300
Faculty \ School:	Faculty of Science > School of Environmental Sciences
UEA Research Groups:	Faculty of Science > Research Groups > Environmental Social Sciences
Depositing User:	LivePure Connector
Date Deposited:	05 Aug 2019 13:30
Last Modified:	22 Oct 2022 05:06
URI:	https://ueaeprints.uea.ac.uk/id/eprint/71884
DOI:	10.1016/j.jclepro.2019.117719

Downloads

Actions (login required)

View Item